Janssen
Scope
Date
~
-
Bio & PharmaSamsung Biologics signs ADC CDO deal with LegoChem Bio
Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...
Feb 07, 2024 (Gmt+09:00)
-
Bio & PharmaLegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)
-
Bio & PharmaJ&J seeks US, European approval for drug developed with Yuhan
Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...
Dec 22, 2023 (Gmt+09:00)
-
Bio & PharmaSK Plasma, Janssen Korea sign sales, distribution agreement
SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...
Feb 14, 2023 (Gmt+09:00)
-
Bio & PharmaCelltrion to seek FDA approval for sale of Remsima SC by year-end
Celltrion Inc. said it has confirmed the effectiveness and safety of Remsima SC in its third-phase global clinical trials, conducted on 438 patients...
Nov 28, 2022 (Gmt+09:00)
Latest News
- 1 Lee Jae-myung to meet with top business leaders June this week ahead of G7 summit
- 2 Korea to allow non-profits to buy consumer bad loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet
